ProCE Banner Activity

An Interactive Tool for Managing BTK Inhibitor−Associated AEs in Hematologic Malignancies

Tool

Use this Interactive Decision Support Tool to learn strategies to assess and manage adverse events associated with BTK inhibitors from 5 experts in managing patients with hematologic malignancies.

Released: December 06, 2021

Expiration: December 05, 2022

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Additional Information

Program Medium

This program has been made available online.